SCHEMBL10276927

SCHEMBL10276927

NCCCCCCNC(=O)CN

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.52
ALDH1A1 P00352 1/20 0.52
SLC6A5 Q9Y345 2/20 0.50
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
HIF1A Q16665 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
KDM4A O75164 1/20 0.46
TET2 Q6N021 1/20 0.46
DOHH Q9BU89 1/20 0.46
GNAI3 P08754 1/20 0.44
GNAO1 P09471 1/20 0.44
GNAI1 P63096 1/20 0.44
CASP2 P42575 1/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19186288 1.00 PAOX (0.61) PAOXSMN1; SMN2ALDH1A1SLC6A5MAOA
SCHEMBL8351641 0.98 PAOX (0.58) PAOXSMN1; SMN2ALDH1A1SLC6A5MAOA
SCHEMBL24611784 0.93 ALDH1A1 (0.59) PAOXSMN1; SMN2ALDH1A1HIF1AMEN1
SCHEMBL14198854 0.93 ALDH1A1 (0.59) PAOXSMN1; SMN2ALDH1A1HIF1AMEN1
SCHEMBL1886044 0.90
SCHEMBL16853212 0.90 ALDH1A1 (0.55) PAOXSMN1; SMN2ALDH1A1HIF1AMEN1
SCHEMBL9062908 0.86 PAOX (0.61) PAOXSMN1; SMN2ALDH1A1SLC6A5MAOA
SCHEMBL12660515 0.85 MEN1 (0.48) PAOXSMN1; SMN2ALDH1A1HIF1AMEN1
SCHEMBL6255247 0.85 CA12 (0.54) PAOXSMN1; SMN2MEN1KMT2ACASP2
SCHEMBL7208464 0.84 SLC6A5 (0.67) PAOXSMN1; SMN2ALDH1A1SLC6A5HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765934-B2 Methods for conjugating nucleic acids with small molecules KAOHSIUNG MEDICAL UNIVERSITY (TW) 2014-07-01 US disclosed
US-20120177573-A1 METHODS FOR CONJUGATING NUCLEIC ACIDS WITH SMALL MOLECULES KAOHSIUNG MEDICAL UNIVERSITY (TW) 2012-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120177573-A1 METHODS FOR CONJUGATING NUCLEIC ACIDS WITH SMALL MOLECULES RNGTT, POLM, POLRMT PAOX 1530/4885SMN1; SMN2 2853/4885ALDH1A1 840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.